China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this trial is to test the hypothesis that Pitavastatin treatment
compared to Atorvastatin, in patients with dyslipidemia, prediabetes and hypertension, will
have less adverse effect on Hemoglobin A1C (HbA1C), which represents long-term glucose
metabolism.